Todd C. Peterson, Ph.D.
Dr. Peterson has served as a member of the board of directors of Armata Pharmaceuticals since October 2019. Dr. Peterson has more than 35 years of experience in biotechnology and life sciences research and development across the areas of molecular biology, nucleic acids and genomics product and technology development. Dr. Peterson currently serves as Chief Scientific Officer at the Allen Institute in Seattle, Washington, overseeing science and technology strategy and operational, translational and growth initiatives to deliver on its impact mission. Prior to joining the Allen Institute in 2018, he served as Chief Technology Officer at Synthetic Genomics, Inc., a leader in synthetic biology and applied genomics technologies developing a robust portfolio of breakthrough solutions addressing major global issues. Prior to joining Synthetic Genomics, Inc., Dr. Peterson led genomics and synthetic biology R&D at Invitrogen/Life Technologies, a global leader in life science tools. Prior to Life Technologies, he held research and development positions with increasing responsibilities and scope at Genicon Sciences, Trega Biosciences, Hybritech and Gen-Probe where he focused on technology research, product development and commercialization. Dr. Peterson was a postdoctoral fellow at the Max Planck Institute in Cologne Germany after receiving his Ph.D. in Microbiology at the University of Southern California School of Medicine. He obtained his M.A. in Biological Sciences and B.A. in Molecular Biology and Biochemistry at the University of California, Santa Barbara.